Free Trial

Extendicare FY2024 EPS Estimate Lifted by Leede Financial

Extendicare logo with Medical background

Extendicare Inc. (TSE:EXE - Free Report) - Research analysts at Leede Financial lifted their FY2024 EPS estimates for shares of Extendicare in a research note issued on Wednesday, November 13th. Leede Financial analyst D. Loe now expects that the company will post earnings of $1.03 per share for the year, up from their prior estimate of $0.89. The consensus estimate for Extendicare's current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare's FY2027 earnings at $1.49 EPS.

Other equities analysts have also recently issued research reports about the company. Royal Bank of Canada boosted their price objective on Extendicare from C$8.50 to C$9.50 in a report on Monday, August 19th. TD Securities upped their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a "hold" rating in a report on Thursday.

View Our Latest Report on EXE

Extendicare Trading Up 1.3 %

EXE traded up C$0.13 during trading on Friday, reaching C$10.14. The company had a trading volume of 154,705 shares, compared to its average volume of 134,798. The company has a quick ratio of 0.98, a current ratio of 0.60 and a debt-to-equity ratio of 305.80. Extendicare has a 52 week low of C$6.41 and a 52 week high of C$10.43. The stock has a market cap of C$846.39 million, a P/E ratio of 14.91 and a beta of 1.26. The business has a 50 day simple moving average of C$9.27 and a 200-day simple moving average of C$8.15.

Extendicare (TSE:EXE - Get Free Report) last issued its quarterly earnings data on Monday, August 12th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. The business had revenue of C$348.48 million for the quarter, compared to the consensus estimate of C$360.20 million.

Extendicare Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, November 15th. Stockholders of record on Thursday, October 31st will be paid a $0.04 dividend. This represents a $0.48 annualized dividend and a dividend yield of 4.73%. The ex-dividend date is Thursday, October 31st. Extendicare's payout ratio is 70.59%.

About Extendicare

(Get Free Report)

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.

Further Reading

Should you invest $1,000 in Extendicare right now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines